Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Korro Bio (KRRO) Invested Capital (2019 - 2025)

Historic Invested Capital for Korro Bio (KRRO) over the last 7 years, with Q3 2025 value amounting to $99.0 million.

  • Korro Bio's Invested Capital fell 4486.95% to $99.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $99.0 million, marking a year-over-year decrease of 4486.95%. This contributed to the annual value of $160.4 million for FY2024, which is 558.88% down from last year.
  • Per Korro Bio's latest filing, its Invested Capital stood at $99.0 million for Q3 2025, which was down 4486.95% from $115.1 million recorded in Q2 2025.
  • Korro Bio's 5-year Invested Capital high stood at $198.1 million for Q2 2024, and its period low was -$89.0 million during Q4 2022.
  • Moreover, its 5-year median value for Invested Capital was $131.7 million (2021), whereas its average is $115.8 million.
  • Its Invested Capital has fluctuated over the past 5 years, first crashed by 16762.34% in 2022, then skyrocketed by 38896.75% in 2024.
  • Over the past 5 years, Korro Bio's Invested Capital (Quarter) stood at $131.7 million in 2021, then plummeted by 167.62% to -$89.0 million in 2022, then soared by 290.84% to $169.9 million in 2023, then dropped by 5.59% to $160.4 million in 2024, then plummeted by 38.27% to $99.0 million in 2025.
  • Its Invested Capital was $99.0 million in Q3 2025, compared to $115.1 million in Q2 2025 and $139.0 million in Q1 2025.